+关注
Bwhobbies
暂无个人介绍
IP属地:未知
51
关注
2
粉丝
0
主题
0
勋章
主贴
热门
Bwhobbies
2021-12-22
Hows everyone doing?
Bwhobbies
2021-10-07
Like
Wall Street ends higher on optimism about U.S. debt-ceiling deal
Bwhobbies
2021-10-07
Like
@话题虎:【7日打卡】有哪些经验越早知道越好?
Bwhobbies
2021-09-30
Veri goos. LIKE PLEASE
Jobs, Jobs Jobs: October's Focus Turns to Key Employment Data as Fed Waits in Wings
Bwhobbies
2021-09-25
Like
IPO opening reminder: Cue Health opens for trading at $19.2, up 20% from IPO price.
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4093155422796600,"uuid":"4093155422796600","gmtCreate":1630052746395,"gmtModify":1630379673125,"name":"Bwhobbies","pinyin":"bwhobbies","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/1dadb619b1899cb53de983314df93b72","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":51,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.04","exceedPercentage":"93.28%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.07.13","exceedPercentage":"93.39%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.04.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691996950,"gmtCreate":1640109388277,"gmtModify":1640109388381,"author":{"id":"4093155422796600","authorId":"4093155422796600","name":"Bwhobbies","avatar":"https://static.tigerbbs.com/1dadb619b1899cb53de983314df93b72","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Hows everyone doing? ","listText":"Hows everyone doing? ","text":"Hows everyone doing?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691996950","isVote":1,"tweetType":1,"viewCount":50,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829776670,"gmtCreate":1633562493649,"gmtModify":1633562493778,"author":{"id":"4093155422796600","authorId":"4093155422796600","name":"Bwhobbies","avatar":"https://static.tigerbbs.com/1dadb619b1899cb53de983314df93b72","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/829776670","repostId":"2173948202","repostType":4,"repost":{"id":"2173948202","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633560167,"share":"https://www.laohu8.com/m/news/2173948202?lang=&edition=full","pubTime":"2021-10-07 06:42","market":"us","language":"en","title":"Wall Street ends higher on optimism about U.S. debt-ceiling deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2173948202","media":"Reuters","summary":"ADP shows U.S. private jobs pick up in September\nAmerican Airlines, Nucor fall on GS downgrades\n\n\nAf","content":"<ul>\n <li>ADP shows U.S. private jobs pick up in September</li>\n <li>American Airlines, Nucor fall on GS downgrades</li>\n</ul>\n<ul>\n <li>Affirm shares jumped closed up 20% after online lender partners with Target ahead of holiday shopping season</li>\n</ul>\n<ul>\n <li>Indexes: Dow +0.30%, S&P 500 +0.41%, Nasdaq +0.47%</li>\n</ul>\n<p>Oct 6 (Reuters) - Wall Street ended higher on Wednesday as investors grew more optimistic that congressional Democrats and Republicans could reach a deal to avert a government debt default.</p>\n<p>Top U.S. Senate Republican Mitch McConnell said his party would support an extension of the federal debt ceiling into December. This would head off a historic default that would exact a heavy economic toll.</p>\n<p>\"McConnell made some dovish comments about temporarily extending the debt ceiling,\" said Jay Hatfield, founder and portfolio manager at Infrastructure Capital Advisors. \"That's going to be interpreted in the short-run as positive.\"</p>\n<p>McConnell's offer could provide an off-ramp to a months-long standoff between President Joe Biden's Democrats and McConnell's Republicans, who had been expected on Wednesday to block a third attempt by Senate Democrats to raise the $28.4 trillion debt ceiling.</p>\n<p>Stocks were lower for much of the session after a strong showing of private jobs in September fueled bets the Federal Reserve could start reining in monetary stimulus soon.</p>\n<p>The Dow Jones Industrial Average rose 0.3% to end at 34,416.99 points, while the S&P 500 gained 0.41% to 4,363.55.</p>\n<p>The Nasdaq Composite climbed 0.47% to 14,501.91.</p>\n<p>Mega-cap growth stocks Amazon and Microsoft both rose more than 1% after the benchmark U.S. 10-year Treasury yield retreated from three-month highs by early afternoon.</p>\n<p>The ADP National Employment Report showed private payrolls increased by 568,000 jobs last month. Economists polled by Reuters had forecast a rise of 428,000 jobs.</p>\n<p>\"Positive labor market data comes with the implication that the Fed can tighten policy at a quicker pace. But the fact that hiring is up shouldn't be discounted — it's definitely a good thing in terms of recovery,\" said Mike Loewengart, managing director, investment strategy at E*TRADE Financial.</p>\n<p>The more comprehensive non-farm payrolls data is due on Friday. It is expected to cement the case for the Fed's slowing of asset purchases.</p>\n<p>Oil prices hit multi-year highs early, but crude prices retreated from those highs while the S&P 500 energy sector index slid over 1%, the weakest performer among 11 sector indexes.</p>\n<p>American Airlines Group fell 4.33% after Goldman Sachs cut its rating on the carrier to \"sell\" from \"neutral\".</p>\n<p>Shares in steelmaker Nucor Corp dropped 2.75% after Goldman Sachs lowered its rating to \"neutral\" from \"buy\".</p>\n<p>Affirm shares jumped closed up 20% on Wednesday after retail chainTargetbegan offering its customers the online lender’s installment loan service for purchases of over $100.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.58-to-1 ratio favored decliners.</p>\n<p>The S&P 500 posted 3 new 52-week highs and 9 new lows; the Nasdaq Composite recorded 31 new highs and 241 new lows.</p>\n<p>Volume on U.S. exchanges was 10.6 billion shares, compared with the 11.0 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends higher on optimism about U.S. debt-ceiling deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends higher on optimism about U.S. debt-ceiling deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-07 06:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>ADP shows U.S. private jobs pick up in September</li>\n <li>American Airlines, Nucor fall on GS downgrades</li>\n</ul>\n<ul>\n <li>Affirm shares jumped closed up 20% after online lender partners with Target ahead of holiday shopping season</li>\n</ul>\n<ul>\n <li>Indexes: Dow +0.30%, S&P 500 +0.41%, Nasdaq +0.47%</li>\n</ul>\n<p>Oct 6 (Reuters) - Wall Street ended higher on Wednesday as investors grew more optimistic that congressional Democrats and Republicans could reach a deal to avert a government debt default.</p>\n<p>Top U.S. Senate Republican Mitch McConnell said his party would support an extension of the federal debt ceiling into December. This would head off a historic default that would exact a heavy economic toll.</p>\n<p>\"McConnell made some dovish comments about temporarily extending the debt ceiling,\" said Jay Hatfield, founder and portfolio manager at Infrastructure Capital Advisors. \"That's going to be interpreted in the short-run as positive.\"</p>\n<p>McConnell's offer could provide an off-ramp to a months-long standoff between President Joe Biden's Democrats and McConnell's Republicans, who had been expected on Wednesday to block a third attempt by Senate Democrats to raise the $28.4 trillion debt ceiling.</p>\n<p>Stocks were lower for much of the session after a strong showing of private jobs in September fueled bets the Federal Reserve could start reining in monetary stimulus soon.</p>\n<p>The Dow Jones Industrial Average rose 0.3% to end at 34,416.99 points, while the S&P 500 gained 0.41% to 4,363.55.</p>\n<p>The Nasdaq Composite climbed 0.47% to 14,501.91.</p>\n<p>Mega-cap growth stocks Amazon and Microsoft both rose more than 1% after the benchmark U.S. 10-year Treasury yield retreated from three-month highs by early afternoon.</p>\n<p>The ADP National Employment Report showed private payrolls increased by 568,000 jobs last month. Economists polled by Reuters had forecast a rise of 428,000 jobs.</p>\n<p>\"Positive labor market data comes with the implication that the Fed can tighten policy at a quicker pace. But the fact that hiring is up shouldn't be discounted — it's definitely a good thing in terms of recovery,\" said Mike Loewengart, managing director, investment strategy at E*TRADE Financial.</p>\n<p>The more comprehensive non-farm payrolls data is due on Friday. It is expected to cement the case for the Fed's slowing of asset purchases.</p>\n<p>Oil prices hit multi-year highs early, but crude prices retreated from those highs while the S&P 500 energy sector index slid over 1%, the weakest performer among 11 sector indexes.</p>\n<p>American Airlines Group fell 4.33% after Goldman Sachs cut its rating on the carrier to \"sell\" from \"neutral\".</p>\n<p>Shares in steelmaker Nucor Corp dropped 2.75% after Goldman Sachs lowered its rating to \"neutral\" from \"buy\".</p>\n<p>Affirm shares jumped closed up 20% on Wednesday after retail chainTargetbegan offering its customers the online lender’s installment loan service for purchases of over $100.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.58-to-1 ratio favored decliners.</p>\n<p>The S&P 500 posted 3 new 52-week highs and 9 new lows; the Nasdaq Composite recorded 31 new highs and 241 new lows.</p>\n<p>Volume on U.S. exchanges was 10.6 billion shares, compared with the 11.0 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","AAL":"美国航空","SSO":"两倍做多标普500ETF","IVV":"标普500指数ETF","SDS":"两倍做空标普500ETF","SH":"标普500反向ETF","SPXU":"三倍做空标普500ETF","UPRO":"三倍做多标普500ETF","OEF":"标普100指数ETF-iShares","NUE":"纽柯钢铁",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","MSFT":"微软",".SPX":"S&P 500 Index","OEX":"标普100","AMZN":"亚马逊","COMP":"Compass, Inc.","AFRM":"Affirm Holdings, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173948202","content_text":"ADP shows U.S. private jobs pick up in September\nAmerican Airlines, Nucor fall on GS downgrades\n\n\nAffirm shares jumped closed up 20% after online lender partners with Target ahead of holiday shopping season\n\n\nIndexes: Dow +0.30%, S&P 500 +0.41%, Nasdaq +0.47%\n\nOct 6 (Reuters) - Wall Street ended higher on Wednesday as investors grew more optimistic that congressional Democrats and Republicans could reach a deal to avert a government debt default.\nTop U.S. Senate Republican Mitch McConnell said his party would support an extension of the federal debt ceiling into December. This would head off a historic default that would exact a heavy economic toll.\n\"McConnell made some dovish comments about temporarily extending the debt ceiling,\" said Jay Hatfield, founder and portfolio manager at Infrastructure Capital Advisors. \"That's going to be interpreted in the short-run as positive.\"\nMcConnell's offer could provide an off-ramp to a months-long standoff between President Joe Biden's Democrats and McConnell's Republicans, who had been expected on Wednesday to block a third attempt by Senate Democrats to raise the $28.4 trillion debt ceiling.\nStocks were lower for much of the session after a strong showing of private jobs in September fueled bets the Federal Reserve could start reining in monetary stimulus soon.\nThe Dow Jones Industrial Average rose 0.3% to end at 34,416.99 points, while the S&P 500 gained 0.41% to 4,363.55.\nThe Nasdaq Composite climbed 0.47% to 14,501.91.\nMega-cap growth stocks Amazon and Microsoft both rose more than 1% after the benchmark U.S. 10-year Treasury yield retreated from three-month highs by early afternoon.\nThe ADP National Employment Report showed private payrolls increased by 568,000 jobs last month. Economists polled by Reuters had forecast a rise of 428,000 jobs.\n\"Positive labor market data comes with the implication that the Fed can tighten policy at a quicker pace. But the fact that hiring is up shouldn't be discounted — it's definitely a good thing in terms of recovery,\" said Mike Loewengart, managing director, investment strategy at E*TRADE Financial.\nThe more comprehensive non-farm payrolls data is due on Friday. It is expected to cement the case for the Fed's slowing of asset purchases.\nOil prices hit multi-year highs early, but crude prices retreated from those highs while the S&P 500 energy sector index slid over 1%, the weakest performer among 11 sector indexes.\nAmerican Airlines Group fell 4.33% after Goldman Sachs cut its rating on the carrier to \"sell\" from \"neutral\".\nShares in steelmaker Nucor Corp dropped 2.75% after Goldman Sachs lowered its rating to \"neutral\" from \"buy\".\nAffirm shares jumped closed up 20% on Wednesday after retail chainTargetbegan offering its customers the online lender’s installment loan service for purchases of over $100.\nDeclining issues outnumbered advancing ones on the NYSE by a 1.31-to-1 ratio; on Nasdaq, a 1.58-to-1 ratio favored decliners.\nThe S&P 500 posted 3 new 52-week highs and 9 new lows; the Nasdaq Composite recorded 31 new highs and 241 new lows.\nVolume on U.S. exchanges was 10.6 billion shares, compared with the 11.0 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":114,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829778379,"gmtCreate":1633562427846,"gmtModify":1633562427935,"author":{"id":"4093155422796600","authorId":"4093155422796600","name":"Bwhobbies","avatar":"https://static.tigerbbs.com/1dadb619b1899cb53de983314df93b72","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829778379","repostId":"829880504","repostType":1,"repost":{"id":829880504,"gmtCreate":1633486732005,"gmtModify":1633676055812,"author":{"id":"3502767768442965","authorId":"3502767768442965","name":"话题虎","avatar":"https://static.tigerbbs.com/d418c2def5dc1d094b03270b450f71ce","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"【7日打卡】有哪些经验越早知道越好?","htmlText":"今天是放假第六天啦,马上就要上班咯~哎呦,突然头疼,不知道能不能再请个假😃 说回正题,今天我们来分享一下人生经验吧:有哪些越早知道越好的人生经验? NO.1 有人说,每个人最好有一段一年以上独自生活的时间 离开父母,离开舍友,离开情侣,真正的独自生活,才能尝出这人间的酸甜苦辣,让自己真正的独自蜕变。 NO.2 男人不仅要会识人,更要拥有强壮手臂。 给自己多一份自信,一份健康。 NO.3 人生的每一次成长,都是从“觉得自己是个傻X”开始的,人生每一次的陷入困境,都是从“觉得别人是个傻X”开始的。 学会谦虚和自省,给别人一份宽容,也是在帮助自己。 NO.4 最后还有人说,炒股要趁早,要趁钱儿少。 …… 最后,大家聊一聊: 你认为有哪些经验越早知道越好? 来分享你的人生经验吧! 精彩留言用户可获得666社区积分噢!连续7天打卡的虎友有机会获得老虎月球灯或等值奖品! <a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/HSI\">$恒生指数(HSI)$</a>","listText":"今天是放假第六天啦,马上就要上班咯~哎呦,突然头疼,不知道能不能再请个假😃 说回正题,今天我们来分享一下人生经验吧:有哪些越早知道越好的人生经验? NO.1 有人说,每个人最好有一段一年以上独自生活的时间 离开父母,离开舍友,离开情侣,真正的独自生活,才能尝出这人间的酸甜苦辣,让自己真正的独自蜕变。 NO.2 男人不仅要会识人,更要拥有强壮手臂。 给自己多一份自信,一份健康。 NO.3 人生的每一次成长,都是从“觉得自己是个傻X”开始的,人生每一次的陷入困境,都是从“觉得别人是个傻X”开始的。 学会谦虚和自省,给别人一份宽容,也是在帮助自己。 NO.4 最后还有人说,炒股要趁早,要趁钱儿少。 …… 最后,大家聊一聊: 你认为有哪些经验越早知道越好? 来分享你的人生经验吧! 精彩留言用户可获得666社区积分噢!连续7天打卡的虎友有机会获得老虎月球灯或等值奖品! <a target=\"_blank\" href=\"https://laohu8.com/S/00700\">$腾讯控股(00700)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/HSI\">$恒生指数(HSI)$</a>","text":"今天是放假第六天啦,马上就要上班咯~哎呦,突然头疼,不知道能不能再请个假😃 说回正题,今天我们来分享一下人生经验吧:有哪些越早知道越好的人生经验? NO.1 有人说,每个人最好有一段一年以上独自生活的时间 离开父母,离开舍友,离开情侣,真正的独自生活,才能尝出这人间的酸甜苦辣,让自己真正的独自蜕变。 NO.2 男人不仅要会识人,更要拥有强壮手臂。 给自己多一份自信,一份健康。 NO.3 人生的每一次成长,都是从“觉得自己是个傻X”开始的,人生每一次的陷入困境,都是从“觉得别人是个傻X”开始的。 学会谦虚和自省,给别人一份宽容,也是在帮助自己。 NO.4 最后还有人说,炒股要趁早,要趁钱儿少。 …… 最后,大家聊一聊: 你认为有哪些经验越早知道越好? 来分享你的人生经验吧! 精彩留言用户可获得666社区积分噢!连续7天打卡的虎友有机会获得老虎月球灯或等值奖品! $腾讯控股(00700)$ $恒生指数(HSI)$","images":[{"img":"https://static.tigerbbs.com/74ff425a30cd75a6175d3817761ccb8e","width":"958","height":"778"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/829880504","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"subType":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":21,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":865841579,"gmtCreate":1632970075882,"gmtModify":1632970076007,"author":{"id":"4093155422796600","authorId":"4093155422796600","name":"Bwhobbies","avatar":"https://static.tigerbbs.com/1dadb619b1899cb53de983314df93b72","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Veri goos. LIKE PLEASE","listText":"Veri goos. LIKE PLEASE","text":"Veri goos. LIKE PLEASE","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/865841579","repostId":"1182846518","repostType":4,"repost":{"id":"1182846518","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1632963637,"share":"https://www.laohu8.com/m/news/1182846518?lang=&edition=full","pubTime":"2021-09-30 09:00","market":"us","language":"en","title":"Jobs, Jobs Jobs: October's Focus Turns to Key Employment Data as Fed Waits in Wings","url":"https://stock-news.laohu8.com/highlight/detail?id=1182846518","media":"Benzinga","summary":"For Fed watchers, Sept. 22 was a “eureka” moment that could help determine where Wall Street heads i","content":"<p>For Fed watchers, Sept. 22 was a “eureka” moment that could help determine where Wall Street heads in October. That was the day Fed Chairman Jerome Powell helped light up the market by hinting that a “taper” could be closer than ever.</p>\n<p>While the month ahead includes plenty of potentially market-moving events—including the start of earnings season, potential drama in Washington and China, and a first look at the government’s estimate for Q3 economic growth—the Fed remains the number one story.</p>\n<p>Why this focus on the Fed and what sounds like the esoteric concept of the Fed potentially “tapering” its monetary stimulus? Because it’s arguably top of mind on Wall Street as we head into early October since it has to do with the cost of borrowing money. The Fed has at least started to talk a little bit more in timeframes, and any clarity we get from them as the month continues is probably going to be looked upon very favorably. Remember, uncertainty isn’t Wall Street’s friend. People tend to like clarity.</p>\n<p>For the last year and a half, Fed Chairman Jerome Powell and company have been snapping up $120 billion in bonds each month. It’s a strategy designed to keep borrowing costs low for consumers and help companies stay afloat in these difficult pandemic times.</p>\n<p>However, many investors have been waiting impatiently for the Fed to remove the economy’s training wheels and pull on some gloves to fight rising inflation. It could potentially do both by “tapering,” or trimming, the number of bonds it buys each month.</p>\n<p>A taper announcement “could come as soon as the next meeting” of the Fed in November, Powell said on Sept. 22, though he added that the timing will depend on the economy’s strong performance continuing in coming weeks. The key could end up being the September jobs report that is due for release by the U.S. Department of Labor on Oct. 8.</p>\n<p>It would take a “reasonably good” jobs report to meet the test of progress toward a taper, Powell said. “The test is all but met,” he added, and he doesn’t need to see a “very good” jobs report, just a decent one. Other Fed officials, he added, believe the test for a taper has already been met.</p>\n<p><b>September Jobs Report Front and Center at Start of Month</b></p>\n<p>By specifically calling out the Oct. 8 jobs report, Powell put investors on notice that he and possibly others at the Fed are zeroing in on that data to help them decide their next steps on tapering. That’s very likely going to mean an intense focus on the report by just about anyone involved in the markets.</p>\n<p>It also puts a lot of focus on a single word and how to interpret it once the report comes out. Powell wants to see a “decent” September jobs report to help determine the timing of the taper announcement, but what’s the definition of “decent?”</p>\n<p>Job growth has averaged 750,000 a month over the last three months but came in below 300,000 in August. However, even 200,000 new jobs a month were considered the standard of excellence before the pandemic shut down and reopening.</p>\n<p>What’s decent now might be in the eye of the beholder, but let’s imagine it would have to be at least in the ballpark of the 235,000 jobs created in September, and maybe higher than that. Only Powell really knows.</p>\n<p>It’s a bit early to look for analyst estimates of September jobs growth, but they’re likely to start showing up during the first few days of October. We know that the Delta variant of Covid took a big bite out of August jobs growth, and Delta remained a major issue throughout September. But there were some green shoots in the August report that might help employment growth if they carried through into September.</p>\n<p>The hospitality sector took a big jobs hit in August as restaurants, hotels, airlines, casinos, and other “reopening” businesses slowed hiring due in part to the Delta variant. At the same time, the transportation, warehousing, and manufacturing sectors saw pretty “decent” jobs growth, perhaps a sign of increased demand for products across the economy. If these trends continued in September, it could go part of the way toward getting jobs growth to levels the Fed wants to see.</p>\n<p><b>“Cyclical” Sectors Get Early Boost on Taper Hopes</b></p>\n<p>Immediately after Powell spoke on Sept. 22, the best-performing sectors were Financials and Energy. That’s not too surprising, considering they’re known as “cyclical” sectors that tend to do better when the economy is growing. This trend could flow into early October, barring any major negative news, while so-called “defensive” sectors like Utilities and Staples might find some pressure from the prospect of rising bond yields.</p>\n<p>Although the Fed is probably a long way from actually raising rates, the benchmark 10-year Treasury yield flirted with three-month highs near 1.5% in the days after Powell spoke, and sometimes yields in the market can be a harbinger of what traders think the Fed is ultimately planning to do. The most recent set of Fed projections basically showed a 50/50 chance of a first-rate hike sometime next year.</p>\n<p>At this point, it feels like the market might actually welcome the Fed getting more hawkish because the thing people have arguably worried most about lately is inflation. Tapering and eventually rate hikes are tools the Fed can use to combat rising prices, although Powell thinks the inflation we’re seeing is temporary and caused mainly by supply bottlenecks created as the economy reopens. The September consumer and producer price index reports due in October are likely to get very close attention when they hit the tape.</p>\n<p>If the rise in yields continues into early October, look for bank shares to possibly benefit. A big part of their profitability depends on the rate picture, with higher rates generally helping their margins. The small-cap <b>Russell 2000 Index</b> (RUT) has a heavy weighting toward banks, so if it’s doing well in early October, it might be a signal that people expect a November taper.</p>\n<p>Small-cap strength—if we see it—also could mean there’s more optimism about the domestic economy. These smaller companies tend to do most of their business here in the homeland, so they’re often a good barometer of U.S economic health.</p>\n<p><b>FIGURE 1:WRAPPING UP ANOTHER QUARTER.</b> This year-to-date chart of the <b>Nasdaq 100</b> (NDX—candlestick), the <b>S&P 500 Index</b> (SPX—purple line), and the <b>Russell 2000 Index</b> (RUT—blue line) show the large-cap indices outrunning the small cap RUT in recent weeks after losing ground to it earlier in the year. The “mega-cap” Tech and Communication Services sectors have pulled up the SPX and NDX recently, but now could face pressure from higher bond yields. Data Source: FTSE Russell, S&P Dow Jones Indices, Nasdaq. Chart source: The thinkorswim® platform. <i>For illustrative purposes only. Past performance does not guarantee future results.</i></p>\n<p><b>Riding into Earnings</b></p>\n<p>There’s other stuff going on in October beyond the Fed and the baseball playoffs (go White Sox!). October is the start of Q3 earnings season, beginning with the big banks in the middle of the month and followed by all the “FAANG” stocks and their tech cousin <b>Microsoft</b> The major Wall Street banks like<b> JP Morgan Chase</b> and<b> Goldman Sachs</b> have had impressive earnings performances so far this year and continue to find ways to improve profit despite a lot of headwinds. If the Fed is actually getting serious about a more hawkish policy, rising yields could become another arrow in the banks’ quiver, so to speak. As always, it will be important to listen to what the CEOs in both Financials and other sectors have to say about the economy, particularly any impact from supply chain issues and the Delta variant of Covid.</p>\n<p>Early analyst estimates for Q3 S&P 500 earnings growth have it continuing at historically high levels, but well below Q2’s meteoric performance. Research firm FactSet now predicts 27.6% earnings growth for Q3, up from its prediction of 24.2% on June 30. It’s always good to see estimates gaining ground, because it likely reflects positive guidance from companies. Also, in Q2, more than 85% of S&P 500 companies exceeded analysts’ earnings estimates, FactSet said, so there may be plenty of room for the 27.6% number to rise from here if Q3 is anything like Q2.</p>\n<p><b>China, Debt Ceiling Seen as Possible Pain Points</b></p>\n<p>China could also remain a focus after the Evergrande scare. Late in September, the beleaguered Chinese property developer said it would start making payments on some of its debt. However, Beijing is sending out signals that it might let the real estate giant fail on some of its obligations, namely those held by investors overseas.</p>\n<p>It’s interesting how the Evergrande worries kind of faded into the background a bit after slamming Wall Street on Sept. 20 when a selloff took stocks down sharply for a single day. However, don’t dismiss the Evergrande issue, even if most stock indexes bounced back later that week. For now, it seems to be in the background, but these stories have a habit of coming back.</p>\n<p>Another story closer to home that could bite the market in October is the battle over the debt ceiling in Washington, D.C. Several past Treasury secretaries as well as the current one, Janet Yellen, have warned about the danger to the economy if this issue isn’t put to bed soon. The U.S. nearly defaulted on its debt back in 2011 during a similar congressional fight, and the stock market struggled through that crisis. More struggles can’t be ruled out if this continues, but for now, it feels like investors are basically assuming the issue gets resolved amid continued partisan bickering without too much turbulence. We shall see.</p>\n<p>Besides jobs and inflation data, another key government report to look for in October is the government’s first estimate for Q3 economic growth. The gross domestic product (GDP) report, due Oct. 28, will be the first solid report investors see on how the overall economy reacted to the Delta variant that apparently helped bring down jobs growth and consumer sentiment in August and early September.</p>\n<p>The Fed now projects GDP to rise just 5.9% this year, compared to its 7% forecast in June. This may reflect the Delta variant’s impact. Having said that, the Fed now projects 2023 growth at 3.8%, which is up from its previous 3.3% estimate. The Fed’s GDP projection then slips in 2023 to 2.5%, but that is up slightly from the Fed’s previous estimate.</p>\n<p>Even GDP growth of 5.9% and 3.8% would look pretty impressive considering the under 3% growth people have gotten used to pretty much since the 2008 recession. October won’t ultimately tell the tale on where GDP goes from here, but it could be a good harbinger of how the markets might behave heading into year-end, especially if we get more clarity from the Fed.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jobs, Jobs Jobs: October's Focus Turns to Key Employment Data as Fed Waits in Wings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJobs, Jobs Jobs: October's Focus Turns to Key Employment Data as Fed Waits in Wings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-30 09:00</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>For Fed watchers, Sept. 22 was a “eureka” moment that could help determine where Wall Street heads in October. That was the day Fed Chairman Jerome Powell helped light up the market by hinting that a “taper” could be closer than ever.</p>\n<p>While the month ahead includes plenty of potentially market-moving events—including the start of earnings season, potential drama in Washington and China, and a first look at the government’s estimate for Q3 economic growth—the Fed remains the number one story.</p>\n<p>Why this focus on the Fed and what sounds like the esoteric concept of the Fed potentially “tapering” its monetary stimulus? Because it’s arguably top of mind on Wall Street as we head into early October since it has to do with the cost of borrowing money. The Fed has at least started to talk a little bit more in timeframes, and any clarity we get from them as the month continues is probably going to be looked upon very favorably. Remember, uncertainty isn’t Wall Street’s friend. People tend to like clarity.</p>\n<p>For the last year and a half, Fed Chairman Jerome Powell and company have been snapping up $120 billion in bonds each month. It’s a strategy designed to keep borrowing costs low for consumers and help companies stay afloat in these difficult pandemic times.</p>\n<p>However, many investors have been waiting impatiently for the Fed to remove the economy’s training wheels and pull on some gloves to fight rising inflation. It could potentially do both by “tapering,” or trimming, the number of bonds it buys each month.</p>\n<p>A taper announcement “could come as soon as the next meeting” of the Fed in November, Powell said on Sept. 22, though he added that the timing will depend on the economy’s strong performance continuing in coming weeks. The key could end up being the September jobs report that is due for release by the U.S. Department of Labor on Oct. 8.</p>\n<p>It would take a “reasonably good” jobs report to meet the test of progress toward a taper, Powell said. “The test is all but met,” he added, and he doesn’t need to see a “very good” jobs report, just a decent one. Other Fed officials, he added, believe the test for a taper has already been met.</p>\n<p><b>September Jobs Report Front and Center at Start of Month</b></p>\n<p>By specifically calling out the Oct. 8 jobs report, Powell put investors on notice that he and possibly others at the Fed are zeroing in on that data to help them decide their next steps on tapering. That’s very likely going to mean an intense focus on the report by just about anyone involved in the markets.</p>\n<p>It also puts a lot of focus on a single word and how to interpret it once the report comes out. Powell wants to see a “decent” September jobs report to help determine the timing of the taper announcement, but what’s the definition of “decent?”</p>\n<p>Job growth has averaged 750,000 a month over the last three months but came in below 300,000 in August. However, even 200,000 new jobs a month were considered the standard of excellence before the pandemic shut down and reopening.</p>\n<p>What’s decent now might be in the eye of the beholder, but let’s imagine it would have to be at least in the ballpark of the 235,000 jobs created in September, and maybe higher than that. Only Powell really knows.</p>\n<p>It’s a bit early to look for analyst estimates of September jobs growth, but they’re likely to start showing up during the first few days of October. We know that the Delta variant of Covid took a big bite out of August jobs growth, and Delta remained a major issue throughout September. But there were some green shoots in the August report that might help employment growth if they carried through into September.</p>\n<p>The hospitality sector took a big jobs hit in August as restaurants, hotels, airlines, casinos, and other “reopening” businesses slowed hiring due in part to the Delta variant. At the same time, the transportation, warehousing, and manufacturing sectors saw pretty “decent” jobs growth, perhaps a sign of increased demand for products across the economy. If these trends continued in September, it could go part of the way toward getting jobs growth to levels the Fed wants to see.</p>\n<p><b>“Cyclical” Sectors Get Early Boost on Taper Hopes</b></p>\n<p>Immediately after Powell spoke on Sept. 22, the best-performing sectors were Financials and Energy. That’s not too surprising, considering they’re known as “cyclical” sectors that tend to do better when the economy is growing. This trend could flow into early October, barring any major negative news, while so-called “defensive” sectors like Utilities and Staples might find some pressure from the prospect of rising bond yields.</p>\n<p>Although the Fed is probably a long way from actually raising rates, the benchmark 10-year Treasury yield flirted with three-month highs near 1.5% in the days after Powell spoke, and sometimes yields in the market can be a harbinger of what traders think the Fed is ultimately planning to do. The most recent set of Fed projections basically showed a 50/50 chance of a first-rate hike sometime next year.</p>\n<p>At this point, it feels like the market might actually welcome the Fed getting more hawkish because the thing people have arguably worried most about lately is inflation. Tapering and eventually rate hikes are tools the Fed can use to combat rising prices, although Powell thinks the inflation we’re seeing is temporary and caused mainly by supply bottlenecks created as the economy reopens. The September consumer and producer price index reports due in October are likely to get very close attention when they hit the tape.</p>\n<p>If the rise in yields continues into early October, look for bank shares to possibly benefit. A big part of their profitability depends on the rate picture, with higher rates generally helping their margins. The small-cap <b>Russell 2000 Index</b> (RUT) has a heavy weighting toward banks, so if it’s doing well in early October, it might be a signal that people expect a November taper.</p>\n<p>Small-cap strength—if we see it—also could mean there’s more optimism about the domestic economy. These smaller companies tend to do most of their business here in the homeland, so they’re often a good barometer of U.S economic health.</p>\n<p><b>FIGURE 1:WRAPPING UP ANOTHER QUARTER.</b> This year-to-date chart of the <b>Nasdaq 100</b> (NDX—candlestick), the <b>S&P 500 Index</b> (SPX—purple line), and the <b>Russell 2000 Index</b> (RUT—blue line) show the large-cap indices outrunning the small cap RUT in recent weeks after losing ground to it earlier in the year. The “mega-cap” Tech and Communication Services sectors have pulled up the SPX and NDX recently, but now could face pressure from higher bond yields. Data Source: FTSE Russell, S&P Dow Jones Indices, Nasdaq. Chart source: The thinkorswim® platform. <i>For illustrative purposes only. Past performance does not guarantee future results.</i></p>\n<p><b>Riding into Earnings</b></p>\n<p>There’s other stuff going on in October beyond the Fed and the baseball playoffs (go White Sox!). October is the start of Q3 earnings season, beginning with the big banks in the middle of the month and followed by all the “FAANG” stocks and their tech cousin <b>Microsoft</b> The major Wall Street banks like<b> JP Morgan Chase</b> and<b> Goldman Sachs</b> have had impressive earnings performances so far this year and continue to find ways to improve profit despite a lot of headwinds. If the Fed is actually getting serious about a more hawkish policy, rising yields could become another arrow in the banks’ quiver, so to speak. As always, it will be important to listen to what the CEOs in both Financials and other sectors have to say about the economy, particularly any impact from supply chain issues and the Delta variant of Covid.</p>\n<p>Early analyst estimates for Q3 S&P 500 earnings growth have it continuing at historically high levels, but well below Q2’s meteoric performance. Research firm FactSet now predicts 27.6% earnings growth for Q3, up from its prediction of 24.2% on June 30. It’s always good to see estimates gaining ground, because it likely reflects positive guidance from companies. Also, in Q2, more than 85% of S&P 500 companies exceeded analysts’ earnings estimates, FactSet said, so there may be plenty of room for the 27.6% number to rise from here if Q3 is anything like Q2.</p>\n<p><b>China, Debt Ceiling Seen as Possible Pain Points</b></p>\n<p>China could also remain a focus after the Evergrande scare. Late in September, the beleaguered Chinese property developer said it would start making payments on some of its debt. However, Beijing is sending out signals that it might let the real estate giant fail on some of its obligations, namely those held by investors overseas.</p>\n<p>It’s interesting how the Evergrande worries kind of faded into the background a bit after slamming Wall Street on Sept. 20 when a selloff took stocks down sharply for a single day. However, don’t dismiss the Evergrande issue, even if most stock indexes bounced back later that week. For now, it seems to be in the background, but these stories have a habit of coming back.</p>\n<p>Another story closer to home that could bite the market in October is the battle over the debt ceiling in Washington, D.C. Several past Treasury secretaries as well as the current one, Janet Yellen, have warned about the danger to the economy if this issue isn’t put to bed soon. The U.S. nearly defaulted on its debt back in 2011 during a similar congressional fight, and the stock market struggled through that crisis. More struggles can’t be ruled out if this continues, but for now, it feels like investors are basically assuming the issue gets resolved amid continued partisan bickering without too much turbulence. We shall see.</p>\n<p>Besides jobs and inflation data, another key government report to look for in October is the government’s first estimate for Q3 economic growth. The gross domestic product (GDP) report, due Oct. 28, will be the first solid report investors see on how the overall economy reacted to the Delta variant that apparently helped bring down jobs growth and consumer sentiment in August and early September.</p>\n<p>The Fed now projects GDP to rise just 5.9% this year, compared to its 7% forecast in June. This may reflect the Delta variant’s impact. Having said that, the Fed now projects 2023 growth at 3.8%, which is up from its previous 3.3% estimate. The Fed’s GDP projection then slips in 2023 to 2.5%, but that is up slightly from the Fed’s previous estimate.</p>\n<p>Even GDP growth of 5.9% and 3.8% would look pretty impressive considering the under 3% growth people have gotten used to pretty much since the 2008 recession. October won’t ultimately tell the tale on where GDP goes from here, but it could be a good harbinger of how the markets might behave heading into year-end, especially if we get more clarity from the Fed.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182846518","content_text":"For Fed watchers, Sept. 22 was a “eureka” moment that could help determine where Wall Street heads in October. That was the day Fed Chairman Jerome Powell helped light up the market by hinting that a “taper” could be closer than ever.\nWhile the month ahead includes plenty of potentially market-moving events—including the start of earnings season, potential drama in Washington and China, and a first look at the government’s estimate for Q3 economic growth—the Fed remains the number one story.\nWhy this focus on the Fed and what sounds like the esoteric concept of the Fed potentially “tapering” its monetary stimulus? Because it’s arguably top of mind on Wall Street as we head into early October since it has to do with the cost of borrowing money. The Fed has at least started to talk a little bit more in timeframes, and any clarity we get from them as the month continues is probably going to be looked upon very favorably. Remember, uncertainty isn’t Wall Street’s friend. People tend to like clarity.\nFor the last year and a half, Fed Chairman Jerome Powell and company have been snapping up $120 billion in bonds each month. It’s a strategy designed to keep borrowing costs low for consumers and help companies stay afloat in these difficult pandemic times.\nHowever, many investors have been waiting impatiently for the Fed to remove the economy’s training wheels and pull on some gloves to fight rising inflation. It could potentially do both by “tapering,” or trimming, the number of bonds it buys each month.\nA taper announcement “could come as soon as the next meeting” of the Fed in November, Powell said on Sept. 22, though he added that the timing will depend on the economy’s strong performance continuing in coming weeks. The key could end up being the September jobs report that is due for release by the U.S. Department of Labor on Oct. 8.\nIt would take a “reasonably good” jobs report to meet the test of progress toward a taper, Powell said. “The test is all but met,” he added, and he doesn’t need to see a “very good” jobs report, just a decent one. Other Fed officials, he added, believe the test for a taper has already been met.\nSeptember Jobs Report Front and Center at Start of Month\nBy specifically calling out the Oct. 8 jobs report, Powell put investors on notice that he and possibly others at the Fed are zeroing in on that data to help them decide their next steps on tapering. That’s very likely going to mean an intense focus on the report by just about anyone involved in the markets.\nIt also puts a lot of focus on a single word and how to interpret it once the report comes out. Powell wants to see a “decent” September jobs report to help determine the timing of the taper announcement, but what’s the definition of “decent?”\nJob growth has averaged 750,000 a month over the last three months but came in below 300,000 in August. However, even 200,000 new jobs a month were considered the standard of excellence before the pandemic shut down and reopening.\nWhat’s decent now might be in the eye of the beholder, but let’s imagine it would have to be at least in the ballpark of the 235,000 jobs created in September, and maybe higher than that. Only Powell really knows.\nIt’s a bit early to look for analyst estimates of September jobs growth, but they’re likely to start showing up during the first few days of October. We know that the Delta variant of Covid took a big bite out of August jobs growth, and Delta remained a major issue throughout September. But there were some green shoots in the August report that might help employment growth if they carried through into September.\nThe hospitality sector took a big jobs hit in August as restaurants, hotels, airlines, casinos, and other “reopening” businesses slowed hiring due in part to the Delta variant. At the same time, the transportation, warehousing, and manufacturing sectors saw pretty “decent” jobs growth, perhaps a sign of increased demand for products across the economy. If these trends continued in September, it could go part of the way toward getting jobs growth to levels the Fed wants to see.\n“Cyclical” Sectors Get Early Boost on Taper Hopes\nImmediately after Powell spoke on Sept. 22, the best-performing sectors were Financials and Energy. That’s not too surprising, considering they’re known as “cyclical” sectors that tend to do better when the economy is growing. This trend could flow into early October, barring any major negative news, while so-called “defensive” sectors like Utilities and Staples might find some pressure from the prospect of rising bond yields.\nAlthough the Fed is probably a long way from actually raising rates, the benchmark 10-year Treasury yield flirted with three-month highs near 1.5% in the days after Powell spoke, and sometimes yields in the market can be a harbinger of what traders think the Fed is ultimately planning to do. The most recent set of Fed projections basically showed a 50/50 chance of a first-rate hike sometime next year.\nAt this point, it feels like the market might actually welcome the Fed getting more hawkish because the thing people have arguably worried most about lately is inflation. Tapering and eventually rate hikes are tools the Fed can use to combat rising prices, although Powell thinks the inflation we’re seeing is temporary and caused mainly by supply bottlenecks created as the economy reopens. The September consumer and producer price index reports due in October are likely to get very close attention when they hit the tape.\nIf the rise in yields continues into early October, look for bank shares to possibly benefit. A big part of their profitability depends on the rate picture, with higher rates generally helping their margins. The small-cap Russell 2000 Index (RUT) has a heavy weighting toward banks, so if it’s doing well in early October, it might be a signal that people expect a November taper.\nSmall-cap strength—if we see it—also could mean there’s more optimism about the domestic economy. These smaller companies tend to do most of their business here in the homeland, so they’re often a good barometer of U.S economic health.\nFIGURE 1:WRAPPING UP ANOTHER QUARTER. This year-to-date chart of the Nasdaq 100 (NDX—candlestick), the S&P 500 Index (SPX—purple line), and the Russell 2000 Index (RUT—blue line) show the large-cap indices outrunning the small cap RUT in recent weeks after losing ground to it earlier in the year. The “mega-cap” Tech and Communication Services sectors have pulled up the SPX and NDX recently, but now could face pressure from higher bond yields. Data Source: FTSE Russell, S&P Dow Jones Indices, Nasdaq. Chart source: The thinkorswim® platform. For illustrative purposes only. Past performance does not guarantee future results.\nRiding into Earnings\nThere’s other stuff going on in October beyond the Fed and the baseball playoffs (go White Sox!). October is the start of Q3 earnings season, beginning with the big banks in the middle of the month and followed by all the “FAANG” stocks and their tech cousin Microsoft The major Wall Street banks like JP Morgan Chase and Goldman Sachs have had impressive earnings performances so far this year and continue to find ways to improve profit despite a lot of headwinds. If the Fed is actually getting serious about a more hawkish policy, rising yields could become another arrow in the banks’ quiver, so to speak. As always, it will be important to listen to what the CEOs in both Financials and other sectors have to say about the economy, particularly any impact from supply chain issues and the Delta variant of Covid.\nEarly analyst estimates for Q3 S&P 500 earnings growth have it continuing at historically high levels, but well below Q2’s meteoric performance. Research firm FactSet now predicts 27.6% earnings growth for Q3, up from its prediction of 24.2% on June 30. It’s always good to see estimates gaining ground, because it likely reflects positive guidance from companies. Also, in Q2, more than 85% of S&P 500 companies exceeded analysts’ earnings estimates, FactSet said, so there may be plenty of room for the 27.6% number to rise from here if Q3 is anything like Q2.\nChina, Debt Ceiling Seen as Possible Pain Points\nChina could also remain a focus after the Evergrande scare. Late in September, the beleaguered Chinese property developer said it would start making payments on some of its debt. However, Beijing is sending out signals that it might let the real estate giant fail on some of its obligations, namely those held by investors overseas.\nIt’s interesting how the Evergrande worries kind of faded into the background a bit after slamming Wall Street on Sept. 20 when a selloff took stocks down sharply for a single day. However, don’t dismiss the Evergrande issue, even if most stock indexes bounced back later that week. For now, it seems to be in the background, but these stories have a habit of coming back.\nAnother story closer to home that could bite the market in October is the battle over the debt ceiling in Washington, D.C. Several past Treasury secretaries as well as the current one, Janet Yellen, have warned about the danger to the economy if this issue isn’t put to bed soon. The U.S. nearly defaulted on its debt back in 2011 during a similar congressional fight, and the stock market struggled through that crisis. More struggles can’t be ruled out if this continues, but for now, it feels like investors are basically assuming the issue gets resolved amid continued partisan bickering without too much turbulence. We shall see.\nBesides jobs and inflation data, another key government report to look for in October is the government’s first estimate for Q3 economic growth. The gross domestic product (GDP) report, due Oct. 28, will be the first solid report investors see on how the overall economy reacted to the Delta variant that apparently helped bring down jobs growth and consumer sentiment in August and early September.\nThe Fed now projects GDP to rise just 5.9% this year, compared to its 7% forecast in June. This may reflect the Delta variant’s impact. Having said that, the Fed now projects 2023 growth at 3.8%, which is up from its previous 3.3% estimate. The Fed’s GDP projection then slips in 2023 to 2.5%, but that is up slightly from the Fed’s previous estimate.\nEven GDP growth of 5.9% and 3.8% would look pretty impressive considering the under 3% growth people have gotten used to pretty much since the 2008 recession. October won’t ultimately tell the tale on where GDP goes from here, but it could be a good harbinger of how the markets might behave heading into year-end, especially if we get more clarity from the Fed.","news_type":1},"isVote":1,"tweetType":1,"viewCount":53,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":861257581,"gmtCreate":1632502533043,"gmtModify":1632714927607,"author":{"id":"4093155422796600","authorId":"4093155422796600","name":"Bwhobbies","avatar":"https://static.tigerbbs.com/1dadb619b1899cb53de983314df93b72","crmLevel":4,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/861257581","repostId":"1104085778","repostType":2,"repost":{"id":"1104085778","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632498166,"share":"https://www.laohu8.com/m/news/1104085778?lang=&edition=full","pubTime":"2021-09-24 23:42","market":"us","language":"en","title":"IPO opening reminder: Cue Health opens for trading at $19.2, up 20% from IPO price.","url":"https://stock-news.laohu8.com/highlight/detail?id=1104085778","media":"Tiger Newspress","summary":"(Sept 24) Cue Health Inc. opens for trading at $19.2, up 20% from IPO price.\n\nCompany & Technology\nS","content":"<p>(Sept 24) <a href=\"https://laohu8.com/S/HLTH\">Cue Health Inc.</a> opens for trading at $19.2, up 20% from IPO price.</p>\n<p><img src=\"https://static.tigerbbs.com/c7270662a08ec3dac176aa52bf5cbd1a\" tg-width=\"902\" tg-height=\"560\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Company & Technology</b></p>\n<p>San Diego, California-based Cue was founded to first develop a COVID-19 test kit and integrated information platform for processing and communication.</p>\n<p>Management is headed by co-founder, Chairman and CEO Ayub Khattak, who has been with the firm since inception and holds a B.S. in mathematics from UCLA.</p>\n<p>The company’s primary offerings in its Cue Integrated Care Platform:</p>\n<ul>\n <li><p>Health monitoring system</p></li>\n <li><p>Rader</p></li>\n <li><p>Cartridge</p></li>\n <li><p>Wand</p></li>\n <li><p>Data</p></li>\n <li><p>Delivery apps</p></li>\n <li><p>Enterprise dashboard</p></li>\n <li><p>Ecosystem integrations</p></li>\n</ul>\n<p>Cue has received at least $176 million in equity investment from investors including ACME Capital, Cove Investors, Decheng Capital China Life Sciences, Madrone and NVGA I.</p>\n<p><b>Customer/User Acquisition</b></p>\n<p>The company pursues healthcare provider relationships through its in-house direct sales team focused on healthcare providers, large enterprises and public sector clients.</p>\n<p>Management expects 2021 customer demand for its COVID-19 test kits to exceed its manufacturing capacity.</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have varied as revenues have increased sharply, as the figures below indicate:</p>\n<table>\n <tbody>\n <tr>\n <td><p><b>Sales and Marketing</b></p></td>\n <td><p><b>Expenses vs. Revenue</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Percentage</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>1.0%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>3.1%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>1.3%</p></td>\n </tr>\n </tbody>\n</table>\n<p>The Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, was 100.5x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <tbody>\n <tr>\n <td><p><b>Sales and Marketing</b></p></td>\n <td><p><b>Efficiency Rate</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Multiple</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>100.5</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>22.9</p></td>\n </tr>\n </tbody>\n</table>\n<p><b>Market & Competition</b></p>\n<p>According to a 2020 marketresearch reportby Grand View Research, the global market for COVID-19 detection kits was an estimated $3.28 billion in 2020 and is expected to reach $5 billion by 2027.</p>\n<p>This represents a forecast CAGR of 5.05% from 2021 to 2027.</p>\n<p>The main drivers for this expected growth are a strong growth in demand for testing services of all types on a global basis.</p>\n<p>Also, below is a chart showing the market share of use of detection kits by end-user type:</p>\n<p><img src=\"https://static.tigerbbs.com/4b7fc60b336bae7685e08132f8176b57\" tg-width=\"1158\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>(Source)</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li><p>Abbott Laboratories(NYSE:ABT)</p></li>\n <li><p>Becton, Dickinson(NYSE:BDX)</p></li>\n <li><p>bioMerieux(OTCPK:BMXMF)</p></li>\n <li><p>Bio-Rad Laboratories(NYSE:BIO)</p></li>\n <li><p>Danaher(NYSE:DHR)</p></li>\n <li><p>Ellume Limited</p></li>\n <li><p>Everly Health</p></li>\n <li><p>Roche(OTCQX:RHHBY)(OTCQX:RHHBF)</p></li>\n <li><p>Fluidigm(NASDAQ:FLDM)</p></li>\n <li><p>GenMark Diagnostics(NASDAQ:GNMK)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Cue’s recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Sharply growing top line revenue</p></li>\n <li><p>Increasing gross profit and variable gross margin</p></li>\n <li><p>A swing to operating profit and net income</p></li>\n <li><p>Variable cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n <tr>\n <td><p><b>Total Revenue</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Total Revenue</p></td>\n <td><p>% Variance vs. Prior</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 201,922,000</p></td>\n <td><p>3971.0%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ 22,953,000</p></td>\n <td><p>246.4%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ 6,626,000</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Gross Profit (Loss)</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Gross Profit (Loss)</p></td>\n <td><p>% Variance vs. Prior</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 116,745,000</p></td>\n <td><p>2253.7%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ 8,002,000</p></td>\n <td><p>20.8%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ 6,626,000</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Gross Margin</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Gross Margin</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>57.82%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>34.86%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>100.00%</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Operating Profit (Loss)</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Operating Profit (Loss)</p></td>\n <td><p>Operating Margin</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 79,463,000</p></td>\n <td><p>39.4%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ (45,126,000)</p></td>\n <td><p>-196.6%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ (20,767,000)</p></td>\n <td><p>-313.4%</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Net Income (Loss)</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Net Income (Loss)</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 32,840,000</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ (47,352,000)</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ (20,606,000)</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Cash Flow From Operations</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Cash Flow From Operations</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ (37,812,000)</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ 92,655,000</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ (12,996,000)</p></td>\n </tr>\n </tbody>\n</table>\n<p>As of June 30, 2021, Cue had $246.3 million in cash and $516.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($60 million).</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of relevant capitalization and valuation figures for the company:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n <tr>\n <td><p><b>Measure [TTM]</b></p></td>\n <td><p><b>Amount</b></p></td>\n </tr>\n <tr>\n <td><p>Market Capitalization at IPO</p></td>\n <td><p>$2,299,981,232</p></td>\n </tr>\n <tr>\n <td><p>Enterprise Value</p></td>\n <td><p>$1,874,455,232</p></td>\n </tr>\n <tr>\n <td><p>Price / Sales</p></td>\n <td><p>10.46</p></td>\n </tr>\n <tr>\n <td><p>EV / Revenue</p></td>\n <td><p>8.52</p></td>\n </tr>\n <tr>\n <td><p>EV / EBITDA</p></td>\n <td><p>35.46</p></td>\n </tr>\n <tr>\n <td><p>Earnings Per Share</p></td>\n <td><p>$0.03</p></td>\n </tr>\n <tr>\n <td><p>Float To Outstanding Shares Ratio</p></td>\n <td><p>8.70%</p></td>\n </tr>\n <tr>\n <td><p>Proposed IPO Midpoint Price per Share</p></td>\n <td><p>$16.00</p></td>\n </tr>\n <tr>\n <td><p>Net Free Cash Flow</p></td>\n <td><p>-$59,920,000</p></td>\n </tr>\n <tr>\n <td><p>Free Cash Flow Yield Per Share</p></td>\n <td><p>-2.61%</p></td>\n </tr>\n <tr>\n <td><p>Revenue Growth Rate</p></td>\n <td><p>3971.01%</p></td>\n </tr>\n </tbody>\n</table>\n<p>As a reference, a potential partial and imperfect public comparable to Cue would be Bio-Rad (BIO); below is a comparison of their primary valuation metrics:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n <tr>\n <td><p><b>Metric</b></p></td>\n <td><p><b>Bio-Rad (BIO)</b></p></td>\n <td><p><b>Cue Health (HLTH)</b></p></td>\n <td><p><b>Variance</b></p></td>\n </tr>\n <tr>\n <td><p>Price / Sales</p></td>\n <td><p>8.15</p></td>\n <td><p>10.46</p></td>\n <td><p>28.3%</p></td>\n </tr>\n <tr>\n <td><p>EV / Revenue</p></td>\n <td><p>7.82</p></td>\n <td><p>8.52</p></td>\n <td><p>9.0%</p></td>\n </tr>\n <tr>\n <td><p>EV / EBITDA</p></td>\n <td><p>31.66</p></td>\n <td><p>35.46</p></td>\n <td><p>12.0%</p></td>\n </tr>\n <tr>\n <td><p>Earnings Per Share</p></td>\n <td><p>$134.05</p></td>\n <td><p>$0.03</p></td>\n <td><p>-100.0%</p></td>\n </tr>\n <tr>\n <td><p>Revenue Growth Rate</p></td>\n <td><p>25.6%</p></td>\n <td><p>3971.01%</p></td>\n <td><p>15436.03%</p></td>\n </tr>\n <tr>\n <td><p>(Glossary Of Terms)</p></td>\n </tr>\n </tbody>\n</table>\n<p><b>Commentary</b></p>\n<p>Cue is seeking public investment capital to further scale its commercialization operations as well as continue its R & D efforts.</p>\n<p>The company’s financials show sharply growing top line revenue, strong growth in gross profit and variable gross margin, a swing to operating profit and net income and highly fluctuating cash flow from or use in operations</p>\n<p>Free cash flow for the twelve months ended June 30, 2021, was an eye-popping negative ($60 million).</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased dramatically; its Sales and Marketing efficiency rate was an extremely high 100.5x in the most recent reporting period.</p>\n<p>The market opportunity for COVID-19 and related test kit platforms is large and will likely grow at a high rate of growth over the coming years as countries around the world seek to bolster their testing capabilities in the wake of the recent global pandemic.</p>\n<p>Goldman Sachs is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 39.9% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the firm now is that it is essentially a one-product company, so its revenue base is heavily concentrated.</p>\n<p>As for valuation, compared to partial competitor Bio-Rad Laboratories, the IPO is reasonably valued on a revenue multiple, although Cue is growing at a much higher rate of growth from a much lower revenue base, so the comparison is strained at best.</p>\n<p>Given Cue’s growth trajectory, profitability and reasonable IPO valuation, the IPO is worth consideration.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPO opening reminder: Cue Health opens for trading at $19.2, up 20% from IPO price.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPO opening reminder: Cue Health opens for trading at $19.2, up 20% from IPO price.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-24 23:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 24) <a href=\"https://laohu8.com/S/HLTH\">Cue Health Inc.</a> opens for trading at $19.2, up 20% from IPO price.</p>\n<p><img src=\"https://static.tigerbbs.com/c7270662a08ec3dac176aa52bf5cbd1a\" tg-width=\"902\" tg-height=\"560\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Company & Technology</b></p>\n<p>San Diego, California-based Cue was founded to first develop a COVID-19 test kit and integrated information platform for processing and communication.</p>\n<p>Management is headed by co-founder, Chairman and CEO Ayub Khattak, who has been with the firm since inception and holds a B.S. in mathematics from UCLA.</p>\n<p>The company’s primary offerings in its Cue Integrated Care Platform:</p>\n<ul>\n <li><p>Health monitoring system</p></li>\n <li><p>Rader</p></li>\n <li><p>Cartridge</p></li>\n <li><p>Wand</p></li>\n <li><p>Data</p></li>\n <li><p>Delivery apps</p></li>\n <li><p>Enterprise dashboard</p></li>\n <li><p>Ecosystem integrations</p></li>\n</ul>\n<p>Cue has received at least $176 million in equity investment from investors including ACME Capital, Cove Investors, Decheng Capital China Life Sciences, Madrone and NVGA I.</p>\n<p><b>Customer/User Acquisition</b></p>\n<p>The company pursues healthcare provider relationships through its in-house direct sales team focused on healthcare providers, large enterprises and public sector clients.</p>\n<p>Management expects 2021 customer demand for its COVID-19 test kits to exceed its manufacturing capacity.</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have varied as revenues have increased sharply, as the figures below indicate:</p>\n<table>\n <tbody>\n <tr>\n <td><p><b>Sales and Marketing</b></p></td>\n <td><p><b>Expenses vs. Revenue</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Percentage</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>1.0%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>3.1%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>1.3%</p></td>\n </tr>\n </tbody>\n</table>\n<p>The Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, was 100.5x in the most recent reporting period, as shown in the table below:</p>\n<table>\n <tbody>\n <tr>\n <td><p><b>Sales and Marketing</b></p></td>\n <td><p><b>Efficiency Rate</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Multiple</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>100.5</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>22.9</p></td>\n </tr>\n </tbody>\n</table>\n<p><b>Market & Competition</b></p>\n<p>According to a 2020 marketresearch reportby Grand View Research, the global market for COVID-19 detection kits was an estimated $3.28 billion in 2020 and is expected to reach $5 billion by 2027.</p>\n<p>This represents a forecast CAGR of 5.05% from 2021 to 2027.</p>\n<p>The main drivers for this expected growth are a strong growth in demand for testing services of all types on a global basis.</p>\n<p>Also, below is a chart showing the market share of use of detection kits by end-user type:</p>\n<p><img src=\"https://static.tigerbbs.com/4b7fc60b336bae7685e08132f8176b57\" tg-width=\"1158\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>(Source)</p>\n<p>Major competitive or other industry participants include:</p>\n<ul>\n <li><p>Abbott Laboratories(NYSE:ABT)</p></li>\n <li><p>Becton, Dickinson(NYSE:BDX)</p></li>\n <li><p>bioMerieux(OTCPK:BMXMF)</p></li>\n <li><p>Bio-Rad Laboratories(NYSE:BIO)</p></li>\n <li><p>Danaher(NYSE:DHR)</p></li>\n <li><p>Ellume Limited</p></li>\n <li><p>Everly Health</p></li>\n <li><p>Roche(OTCQX:RHHBY)(OTCQX:RHHBF)</p></li>\n <li><p>Fluidigm(NASDAQ:FLDM)</p></li>\n <li><p>GenMark Diagnostics(NASDAQ:GNMK)</p></li>\n <li><p>Others</p></li>\n</ul>\n<p><b>Financial Performance</b></p>\n<p>Cue’s recent financial results can be summarized as follows:</p>\n<ul>\n <li><p>Sharply growing top line revenue</p></li>\n <li><p>Increasing gross profit and variable gross margin</p></li>\n <li><p>A swing to operating profit and net income</p></li>\n <li><p>Variable cash flow from operations</p></li>\n</ul>\n<p>Below are relevant financial results derived from the firm’s registration statement:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n <tr>\n <td><p><b>Total Revenue</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Total Revenue</p></td>\n <td><p>% Variance vs. Prior</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 201,922,000</p></td>\n <td><p>3971.0%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ 22,953,000</p></td>\n <td><p>246.4%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ 6,626,000</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Gross Profit (Loss)</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Gross Profit (Loss)</p></td>\n <td><p>% Variance vs. Prior</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 116,745,000</p></td>\n <td><p>2253.7%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ 8,002,000</p></td>\n <td><p>20.8%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ 6,626,000</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Gross Margin</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Gross Margin</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>57.82%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>34.86%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>100.00%</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Operating Profit (Loss)</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Operating Profit (Loss)</p></td>\n <td><p>Operating Margin</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 79,463,000</p></td>\n <td><p>39.4%</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ (45,126,000)</p></td>\n <td><p>-196.6%</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ (20,767,000)</p></td>\n <td><p>-313.4%</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Net Income (Loss)</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Net Income (Loss)</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ 32,840,000</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ (47,352,000)</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ (20,606,000)</p></td>\n </tr>\n <tr></tr>\n <tr>\n <td><p><b>Cash Flow From Operations</b></p></td>\n </tr>\n <tr>\n <td><p>Period</p></td>\n <td><p>Cash Flow From Operations</p></td>\n </tr>\n <tr>\n <td><p>Six Mos. Ended June 30, 2021</p></td>\n <td><p>$ (37,812,000)</p></td>\n </tr>\n <tr>\n <td><p>2020</p></td>\n <td><p>$ 92,655,000</p></td>\n </tr>\n <tr>\n <td><p>2019</p></td>\n <td><p>$ (12,996,000)</p></td>\n </tr>\n </tbody>\n</table>\n<p>As of June 30, 2021, Cue had $246.3 million in cash and $516.3 million in total liabilities.</p>\n<p>Free cash flow during the twelve months ended June 30, 2021, was negative ($60 million).</p>\n<p><b>Valuation Metrics</b></p>\n<p>Below is a table of relevant capitalization and valuation figures for the company:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n <tr>\n <td><p><b>Measure [TTM]</b></p></td>\n <td><p><b>Amount</b></p></td>\n </tr>\n <tr>\n <td><p>Market Capitalization at IPO</p></td>\n <td><p>$2,299,981,232</p></td>\n </tr>\n <tr>\n <td><p>Enterprise Value</p></td>\n <td><p>$1,874,455,232</p></td>\n </tr>\n <tr>\n <td><p>Price / Sales</p></td>\n <td><p>10.46</p></td>\n </tr>\n <tr>\n <td><p>EV / Revenue</p></td>\n <td><p>8.52</p></td>\n </tr>\n <tr>\n <td><p>EV / EBITDA</p></td>\n <td><p>35.46</p></td>\n </tr>\n <tr>\n <td><p>Earnings Per Share</p></td>\n <td><p>$0.03</p></td>\n </tr>\n <tr>\n <td><p>Float To Outstanding Shares Ratio</p></td>\n <td><p>8.70%</p></td>\n </tr>\n <tr>\n <td><p>Proposed IPO Midpoint Price per Share</p></td>\n <td><p>$16.00</p></td>\n </tr>\n <tr>\n <td><p>Net Free Cash Flow</p></td>\n <td><p>-$59,920,000</p></td>\n </tr>\n <tr>\n <td><p>Free Cash Flow Yield Per Share</p></td>\n <td><p>-2.61%</p></td>\n </tr>\n <tr>\n <td><p>Revenue Growth Rate</p></td>\n <td><p>3971.01%</p></td>\n </tr>\n </tbody>\n</table>\n<p>As a reference, a potential partial and imperfect public comparable to Cue would be Bio-Rad (BIO); below is a comparison of their primary valuation metrics:</p>\n<table>\n <colgroup></colgroup>\n <tbody>\n <tr>\n <td><p><b>Metric</b></p></td>\n <td><p><b>Bio-Rad (BIO)</b></p></td>\n <td><p><b>Cue Health (HLTH)</b></p></td>\n <td><p><b>Variance</b></p></td>\n </tr>\n <tr>\n <td><p>Price / Sales</p></td>\n <td><p>8.15</p></td>\n <td><p>10.46</p></td>\n <td><p>28.3%</p></td>\n </tr>\n <tr>\n <td><p>EV / Revenue</p></td>\n <td><p>7.82</p></td>\n <td><p>8.52</p></td>\n <td><p>9.0%</p></td>\n </tr>\n <tr>\n <td><p>EV / EBITDA</p></td>\n <td><p>31.66</p></td>\n <td><p>35.46</p></td>\n <td><p>12.0%</p></td>\n </tr>\n <tr>\n <td><p>Earnings Per Share</p></td>\n <td><p>$134.05</p></td>\n <td><p>$0.03</p></td>\n <td><p>-100.0%</p></td>\n </tr>\n <tr>\n <td><p>Revenue Growth Rate</p></td>\n <td><p>25.6%</p></td>\n <td><p>3971.01%</p></td>\n <td><p>15436.03%</p></td>\n </tr>\n <tr>\n <td><p>(Glossary Of Terms)</p></td>\n </tr>\n </tbody>\n</table>\n<p><b>Commentary</b></p>\n<p>Cue is seeking public investment capital to further scale its commercialization operations as well as continue its R & D efforts.</p>\n<p>The company’s financials show sharply growing top line revenue, strong growth in gross profit and variable gross margin, a swing to operating profit and net income and highly fluctuating cash flow from or use in operations</p>\n<p>Free cash flow for the twelve months ended June 30, 2021, was an eye-popping negative ($60 million).</p>\n<p>Sales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased dramatically; its Sales and Marketing efficiency rate was an extremely high 100.5x in the most recent reporting period.</p>\n<p>The market opportunity for COVID-19 and related test kit platforms is large and will likely grow at a high rate of growth over the coming years as countries around the world seek to bolster their testing capabilities in the wake of the recent global pandemic.</p>\n<p>Goldman Sachs is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 39.9% since their IPO. This is a mid-tier performance for all major underwriters during the period.</p>\n<p>The primary risk to the firm now is that it is essentially a one-product company, so its revenue base is heavily concentrated.</p>\n<p>As for valuation, compared to partial competitor Bio-Rad Laboratories, the IPO is reasonably valued on a revenue multiple, although Cue is growing at a much higher rate of growth from a much lower revenue base, so the comparison is strained at best.</p>\n<p>Given Cue’s growth trajectory, profitability and reasonable IPO valuation, the IPO is worth consideration.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HLTH":"Cue Health Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104085778","content_text":"(Sept 24) Cue Health Inc. opens for trading at $19.2, up 20% from IPO price.\n\nCompany & Technology\nSan Diego, California-based Cue was founded to first develop a COVID-19 test kit and integrated information platform for processing and communication.\nManagement is headed by co-founder, Chairman and CEO Ayub Khattak, who has been with the firm since inception and holds a B.S. in mathematics from UCLA.\nThe company’s primary offerings in its Cue Integrated Care Platform:\n\nHealth monitoring system\nRader\nCartridge\nWand\nData\nDelivery apps\nEnterprise dashboard\nEcosystem integrations\n\nCue has received at least $176 million in equity investment from investors including ACME Capital, Cove Investors, Decheng Capital China Life Sciences, Madrone and NVGA I.\nCustomer/User Acquisition\nThe company pursues healthcare provider relationships through its in-house direct sales team focused on healthcare providers, large enterprises and public sector clients.\nManagement expects 2021 customer demand for its COVID-19 test kits to exceed its manufacturing capacity.\nSales and Marketing expenses as a percentage of total revenue have varied as revenues have increased sharply, as the figures below indicate:\n\n\n\nSales and Marketing\nExpenses vs. Revenue\n\n\nPeriod\nPercentage\n\n\nSix Mos. Ended June 30, 2021\n1.0%\n\n\n2020\n3.1%\n\n\n2019\n1.3%\n\n\n\nThe Sales and Marketing efficiency rate, defined as how many dollars of additional new revenue are generated by each dollar of Sales and Marketing spend, was 100.5x in the most recent reporting period, as shown in the table below:\n\n\n\nSales and Marketing\nEfficiency Rate\n\n\nPeriod\nMultiple\n\n\nSix Mos. Ended June 30, 2021\n100.5\n\n\n2020\n22.9\n\n\n\nMarket & Competition\nAccording to a 2020 marketresearch reportby Grand View Research, the global market for COVID-19 detection kits was an estimated $3.28 billion in 2020 and is expected to reach $5 billion by 2027.\nThis represents a forecast CAGR of 5.05% from 2021 to 2027.\nThe main drivers for this expected growth are a strong growth in demand for testing services of all types on a global basis.\nAlso, below is a chart showing the market share of use of detection kits by end-user type:\n\n(Source)\nMajor competitive or other industry participants include:\n\nAbbott Laboratories(NYSE:ABT)\nBecton, Dickinson(NYSE:BDX)\nbioMerieux(OTCPK:BMXMF)\nBio-Rad Laboratories(NYSE:BIO)\nDanaher(NYSE:DHR)\nEllume Limited\nEverly Health\nRoche(OTCQX:RHHBY)(OTCQX:RHHBF)\nFluidigm(NASDAQ:FLDM)\nGenMark Diagnostics(NASDAQ:GNMK)\nOthers\n\nFinancial Performance\nCue’s recent financial results can be summarized as follows:\n\nSharply growing top line revenue\nIncreasing gross profit and variable gross margin\nA swing to operating profit and net income\nVariable cash flow from operations\n\nBelow are relevant financial results derived from the firm’s registration statement:\n\n\n\n\nTotal Revenue\n\n\nPeriod\nTotal Revenue\n% Variance vs. Prior\n\n\nSix Mos. Ended June 30, 2021\n$ 201,922,000\n3971.0%\n\n\n2020\n$ 22,953,000\n246.4%\n\n\n2019\n$ 6,626,000\n\n\n\nGross Profit (Loss)\n\n\nPeriod\nGross Profit (Loss)\n% Variance vs. Prior\n\n\nSix Mos. Ended June 30, 2021\n$ 116,745,000\n2253.7%\n\n\n2020\n$ 8,002,000\n20.8%\n\n\n2019\n$ 6,626,000\n\n\n\nGross Margin\n\n\nPeriod\nGross Margin\n\n\nSix Mos. Ended June 30, 2021\n57.82%\n\n\n2020\n34.86%\n\n\n2019\n100.00%\n\n\n\nOperating Profit (Loss)\n\n\nPeriod\nOperating Profit (Loss)\nOperating Margin\n\n\nSix Mos. Ended June 30, 2021\n$ 79,463,000\n39.4%\n\n\n2020\n$ (45,126,000)\n-196.6%\n\n\n2019\n$ (20,767,000)\n-313.4%\n\n\n\nNet Income (Loss)\n\n\nPeriod\nNet Income (Loss)\n\n\nSix Mos. Ended June 30, 2021\n$ 32,840,000\n\n\n2020\n$ (47,352,000)\n\n\n2019\n$ (20,606,000)\n\n\n\nCash Flow From Operations\n\n\nPeriod\nCash Flow From Operations\n\n\nSix Mos. Ended June 30, 2021\n$ (37,812,000)\n\n\n2020\n$ 92,655,000\n\n\n2019\n$ (12,996,000)\n\n\n\nAs of June 30, 2021, Cue had $246.3 million in cash and $516.3 million in total liabilities.\nFree cash flow during the twelve months ended June 30, 2021, was negative ($60 million).\nValuation Metrics\nBelow is a table of relevant capitalization and valuation figures for the company:\n\n\n\n\nMeasure [TTM]\nAmount\n\n\nMarket Capitalization at IPO\n$2,299,981,232\n\n\nEnterprise Value\n$1,874,455,232\n\n\nPrice / Sales\n10.46\n\n\nEV / Revenue\n8.52\n\n\nEV / EBITDA\n35.46\n\n\nEarnings Per Share\n$0.03\n\n\nFloat To Outstanding Shares Ratio\n8.70%\n\n\nProposed IPO Midpoint Price per Share\n$16.00\n\n\nNet Free Cash Flow\n-$59,920,000\n\n\nFree Cash Flow Yield Per Share\n-2.61%\n\n\nRevenue Growth Rate\n3971.01%\n\n\n\nAs a reference, a potential partial and imperfect public comparable to Cue would be Bio-Rad (BIO); below is a comparison of their primary valuation metrics:\n\n\n\n\nMetric\nBio-Rad (BIO)\nCue Health (HLTH)\nVariance\n\n\nPrice / Sales\n8.15\n10.46\n28.3%\n\n\nEV / Revenue\n7.82\n8.52\n9.0%\n\n\nEV / EBITDA\n31.66\n35.46\n12.0%\n\n\nEarnings Per Share\n$134.05\n$0.03\n-100.0%\n\n\nRevenue Growth Rate\n25.6%\n3971.01%\n15436.03%\n\n\n(Glossary Of Terms)\n\n\n\nCommentary\nCue is seeking public investment capital to further scale its commercialization operations as well as continue its R & D efforts.\nThe company’s financials show sharply growing top line revenue, strong growth in gross profit and variable gross margin, a swing to operating profit and net income and highly fluctuating cash flow from or use in operations\nFree cash flow for the twelve months ended June 30, 2021, was an eye-popping negative ($60 million).\nSales and Marketing expenses as a percentage of total revenue have fluctuated as revenues have increased dramatically; its Sales and Marketing efficiency rate was an extremely high 100.5x in the most recent reporting period.\nThe market opportunity for COVID-19 and related test kit platforms is large and will likely grow at a high rate of growth over the coming years as countries around the world seek to bolster their testing capabilities in the wake of the recent global pandemic.\nGoldman Sachs is the lead left underwriter and IPOs led by the firm over the last 12-month period have generated an average return of 39.9% since their IPO. This is a mid-tier performance for all major underwriters during the period.\nThe primary risk to the firm now is that it is essentially a one-product company, so its revenue base is heavily concentrated.\nAs for valuation, compared to partial competitor Bio-Rad Laboratories, the IPO is reasonably valued on a revenue multiple, although Cue is growing at a much higher rate of growth from a much lower revenue base, so the comparison is strained at best.\nGiven Cue’s growth trajectory, profitability and reasonable IPO valuation, the IPO is worth consideration.","news_type":1},"isVote":1,"tweetType":1,"viewCount":9,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[],"lives":[]}